Interview: Comprehensive, patient-friendly risk assessment “crucial” to VTE prevention
From the first research linking heparin to a reduction in fatal pulmonary embolism (PE), to the development and refinement of risk assessment tools to...
CX to tackle key controversies in the venous space
Lowell Kabnick (Lake Worth, USA) talks to Venous News ahead of this year’s Charing Cross Symposium (CX), which is being held online 19–22 April. In...
Three-year data add to growing body of clinical evidence in support of VICI Venous...
This advertorial is sponsored by Boston Scientific.
The VICI Venous Stent System (Boston Scientific) is associated with excellent primary patency rates, with concomitant symptomatic improvement...
A multidisciplinary approach to VTE in COVID-19 patients is warranted
The nature of venous thromboembolism (VTE) in COVID-19 patients is complex, and treatment strategies regarding drug type and dosing continue to evolve, writes Sanjum...
